Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-02

Clinical Trial Update: A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of MK-0773 in women with sarcopenia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK-0773

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Sarcopenia | Phase 2 | Status: COMPLETED | Results posted: 2012-07-02